Vidas Equine Insulin provides insulin levels in approximately 20 minutes, which the company says will help with the diagnosis and management of Equine Metabolic Syndrome (EMS), commonly associated with insulin dysregulation in horses.
Vidas Equine ACTH provides dysregulation level testing of the adrenocorticotropic (ACTH) hormone related to the development of Equine Cushing’s Disease (aka Pituitary Pars Intermedia Dysfunction - PPID) in about 45 minutes.
Pierre Rouppert, Global Veterinary Product Manager at bioMérieux, said: “Our new endocrinology tests, because of their rapidity and ease of use, will bring clinical value for veterinary practices, directly at the Point of Care.
"Equine Metabolic Syndrome and Cushing’s Disease are chronic conditions that often evade detection in their initial stages, making early testing crucial in achieving proper management and animal care.”
David Smart, Global Veterinary Business Developer at bioMérieux, said: “This dedicated equine immunoassay test for insulin and ACTH represents a transformative step forward in animal care.
"Veterinary practitioners will be able to achieve fast, reliable and cost-effective laboratory grade results that can aid early detection and subsequent diagnosis for two prolific and debilitating medical conditions in horses.
"The fast and accurate results from these two new tests will allow quicker clinical decisions that will ultimately help more horses receive an improved standard of care and reassure horse owners.”
https://www.biomerieux.com/corp/en/our-offer/clinical-products/vidas-equine-insulin.html
PS: Whilst you're here, take a moment to see our latest job opportunities for vets.